ScholarWorks@SOONCHUNHYANG UNIVERSITY: Lee, Sae Hwan

Detailed Information

Lee, Sae Hwan (이세환)

College of Medicine (Department of Internal Medicine)

Research Area

Tel
E-mail
Homepage

ResearcherID ORCiD Scopus Google Scholar ID ResearchGate

Keyword

Hepatitis B:5||Hepatocellular carcinoma:5||hepatocellular carcinoma:5||Carcinoma:5||hepatocellular:5||Liver cirrhosis:4||Chronic hepatitis B:4||Chronic hepatitis C:4||chronic:4||Hepatitis B virus:4||Diagnosis:3||Korea:3||Sorafenib:3||Clevudine:3||의약학:3||Hepatitis C:2||Ribavirin:2||Hepatitis C virus:2||Entecavir:2||Resistance:2||chronic hepatitis B:2||Survival:2||Sustained virologic response:2||Daclatasvir:2||Transient elastography:2||소화기내과:2||Adefovir:2||Drug resistance:2||Asunaprevir:2||Cirrhosis:2||Chemoembolization:2||Treatment:2||Recurrence:2||Glue injection:2||Esophageal and gastric varices:2||HVPG:2||Duodenal neoplasms:1||EMT:1||Endoscopic retrograde cholangiopancreatography (ERCP):1||Endoscopic submucosal dissection:1||Endosonography:1||Etiology:1||Extrahepatic metastases:1||F18fluorodeoxyglucose positron emission tomography/computed tomography scan:1||Feeding artery:1||Fibroscan 630:1||Fluorodeoxyglucose F18:1||Focal liver lesions (FLLs):1||Fundal varices:1||Gastric varices:1||Gastric varix:1||Gastrointestinal hemorrhage:1||Glecaprevir:1||Glomerular Filtration Rate:1||Glycolysis:1||Guidelines:1||HBV DNA:1||HBV seroconversion:1||HBcrAg:1||HCC:1||Harvoni:1||Hemoclip:1||Hemodialysis:1||Hemorrhage:1||Hepatic arterial infusion chemotherapy:1||Hepatic venous pressure gradient:1||Hepatic venous pressure gradient (HVPG):1||Hepatitis:1||Hepatitis C, Chronic:1||Hepatotoxicity:1||Histoacryl (R) (Nbutyl2cyanoacrylate):1||Histoacryl (R) injection:1||Hospitalization:1||Hypertension, portal:1||Immunohistochemistry:1||Insulin resistance:1||Interferonalpha:1||Interferonα2b:1||Intestinal perforation:1||Koreans:1||Lamivudine:1||Lamivudine Resistance:1||Lamivudine resistance:1||Lipid metabolism:1||Liver Cirrhosis:1||Liver abscess:1||Liver fibrosis:1||Liver injury:1||Liver masses:1||Liver stiffness:1||MTA1:1||Melena:1||Muscle mass:1||Mutation:1||Occult infection:1||Overestimation:1||Overlap syndrome:1||P2RX7:1||PIVKAII:1||Patients with liver cirrhosis and hepatocellular carcinoma (HCC) are often ineligible for resection or local ablation therapy due to poor liver:1||Pegylated interferon:1||Pegylated interferon alpha2b:1||Pibrentasvir:1||Plants, Medicinal:1||Portal hypertension:1||Portal vein:1||Portal vein tumor thrombosis:1||Portasystemic shunt, surgical:1||Positronemission tomography:1||Predictor:1||Prescribed Medicines:1||Primary biliary cirrhosis:1||Prognosis:1||Prophylaxis:1||Proton pump inhibitors:1||Pyogenic:1||Radiationinduced liver disease:1||Realtime elastography:1||Relapse:1||Remission:1||Renal Function:1||Renal insufficiency:1||Rescue Therapy:1||Restriction fragment mass polymorphism:1||Secondary prevention:1||Serum Creatinine Level:1||Sex:1||Sofosbuvir:1||Spleen stiffness:1||Spontaneous Bacterial Peritonitis:1||Stereotactic body radiation therapy:1||Stomach:1||Sustained virological response:1||TRAIL Enhances Apoptosis of Human HepatocellularCarcinoma Cells Sensitized by Hepatitis C Virus Infection:Therapeutic Implications:1||Telbivudine:1||Tenofovir:1||Therapeutic:1||Therapy:1||Thrombosis:1||Tomography:1||Traditional Therapy:1||Transarterial chemoembolization:1||Treatment of gastric varix:1||Treatment outcomes:1||Tumor size:1||Ulcer:1||Ursodeoxycholic acid:1||Variceal hemorrhage:1||Varices:1||Virologic response:1||VogtKoyanagiHarada disease:1||Xray computed:1||ZEB1:1||alternative treatment:1||angiogenesis:1||antiviral therapy:1||cachexia:1||chemoembolization:1||colorectal cancer:1||diagnostic value:1||enhanced ultrasonography:1||ginsenoside Rd:1||health education:1||hepatic arterial infusion chemotherapy:1||hepatitis B virus:1||high cost:1||hyperlipidemia:1||liver transplantation:1||lowMELD:1||miR551b:1||muscle wasting:1||nonalcoholic fatty liver disease:1||noninferiority:1||nutrition:1||nutrition education:1||polymorphism:1||radiofrequency ablation:1||renal function:1||renal insufficiency:1||sarcopenia:1||signal transducer and activator of transcription 3:1||sorafenib:1||stereotactic body radiotherapy:1||survival:1||survival rate:1||tenofovir:1||tenofovir disoproxil orotate:1||therapeutic:1||간 손상:1||간경변:1||내시경역행췌담관조영술:1||담도 스텐트:1||리비탈:1||바이러스반응:1||식도위정맥류:1||십이지장 천공:1||알라닌아미노전달효소:1||약제 내성:1||우루사:1||위장관출혈:1||지혈클립:1||치료:1||25Hydroxyvitamin D deficiency:1||테노포비어:1||AFP:1||AFPL3:1||AKT:1||Acousticradiationforce impulse elastography:1||Afferent loop syndrome:1||Alanine aminotransferase:1||Anemia:1||Autoimmune hepatitis:1||Autologous BMMSC transplantation safely improved histologic fibrosis and liver function in patients with alcoholic cirrhosis:1||Betablocker:1||Biliary stent:1||Biochemical response:1||Biomarkers:1||Biphenyl dimethyl dicarboxylate:1||Blood platelets:1||Bronchial fistula:1||B형간염:1||Carcinoma, hepatocellular:1||Caspase3:1||Cause of death:1||ChildPugh score:1||Chronic:1||Chronic hepatitis C virus:1||Circulating tumor DNA:1||Clinical practice guidelines:1||Complete response:1||Complications:1||Contrast:1||Contrast enhanced Ultrasonography (CEUS):1||Contrast enhanced ultrasonography:1||Cyclooxygenase 2:1||Dialysis:1||Discontinuation:1||Druginduced Liver Injury:1||Druginduced liver injury:1||

RSS_1.0 RSS_2.0 ATOM_1.0

(31538) 22, Soonchunhyang-ro, Asan-si, Chungcheongnam-do, Republic of Korea+82-41-530-1114

Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.

Detailed Information

Keyword

BROWSE